Demystifying Medicine Video

Women with hypoactive sexual desire disorder (HSDD) have very few sexual thoughts or urges. Flibanserin is a drug that treats HSDD in women. It causes a decrease in serotonin and an increase in dopamine, which influences the reward system associated with sexual response. Taking the pill every day was seen to increase satisfying sexual experience occurrences by 0.5 times a month. With a slight comedic undertone, this video promotes awareness of HSDD in women and looks at using Flibanserin to treat the condition.

[Please complete our feedback form]

  • ADDYI® (Flibanserin). Valeant Pharmaceuticals North America LLC. Retrieved 16 October 2017.
  • 'Female Viagra' user: It really works. (August 19, 2015). CNN. Retrieved October 09, 2017.
  • Goldfischer, E. R., Breaux, J., Katz, M., Kaufman, J., Smith, W. B., Kimura, T., ... & Pyke, R. (2011). Continued efficacy and safety of flibanserin in premenopausal women with hypoactive sexual desire disorder (HSDD): Results from a randomized withdrawal trial. The journal of sexual medicine, 8(11), 3160-3170.
  • Jaspers, L., Feys, F., Bramer, W. M., Franco, O. H., Leusink, P., & Laan, E. T. (2016). Efficacy and safety of flibanserin for the treatment of hypoactive sexual desire disorder in women: a systematic review and meta-analysis. JAMA internal medicine, 176(4), 453-462.
  • Jayne, C., Simon, J. A., Taylor, L. V., Kimura, T., & Lesko, L. M. (2012). Openā€label extension study of flibanserin in women with hypoactive sexual desire disorder. The Journal of Sexual Medicine, 9(12), 3180-3188.
  • Rahman, S. Z., Gupta, V., Sukhlecha, A., & Khunte, Y. (2010). Lifestyle Drugs: Concept and Impact on Society. Indian Journal of Pharmaceutical Sciences, 72(4), 409–413. doi:10.4103/0250-474X.73902
  • Sang JH, Kim T-H, Kim SA. Flibanserin for Treating Hypoactive Sexual Desire Disorder. Journal of Menopausal Medicine. 2016;22(1):9-13. doi:10.6118/jmm.2016.22.1.9.
  • Shifren, J. L. (2014, December). The Pharmacologic Treatment of Female Sexual Dysfunction: Future Reality or Wishful Thinking? In Menopause - The Journal of the North American Menopause Society (Vol. 21, No. 12, Pp. 1320-1320). 530 Walnut St, Philadelphia, Pa 19106-3621 USA: Lippincott Williams & Wilkins.
  • Women's libido drug benefits 'marginal' with high risk of side-effects, review says. (2017). CBC News. Retrieved 16 October 2017.